Spanish women are having fewer and fewer children, and yet the country has become the egg donation capital of Europe. In this episode of The Conversation Weekly podcast, we find out about the experiences of women who decide to donate their eggs, and whether there are enough protections in place to prevent them from being exploited.
Over the past 20 years, the number of egg donation cycles in Europe has been steadily increasing, reaching more than 80,000 in 2018. Around half of these take place in Spain, which has positioned itself as Europe’s go-to destination for people seeking donated eggs.
According to Anna Molas, a research fellow in anthropology at the Autonomous University of Barcelona, Spain currently has “the most flexible assisted reproductive law across Europe”. There is no age-limit for women who want to use private clinics, and no access restrictions in terms of marital status or sexual orientation.
An egg donation industry has developed in Spain to feed the demand for donor eggs, much of which is driven by women over the age of 40 who need help to have a baby. Adverts on social media encouraging women to donate their eggs are common. Around 15,000 women go through egg donation cycles every year in Spain.
When Molas interviewed women in Spain about their experiences, she found that the main reason they chose to donate was economic. A donor typically receives €1,100 (US$1,150) for an egg donation cycle, and the amount of compensation increases each time they donate.
“Even if it is a low amount of money for all the process that it involves, it still appeals to a lot of women,” says Molas. However, under Spanish law, donors are considered to be motivated by altruism. “The fact that they are treated as donors, as volunteers, makes it very difficult to have a discussion about how much they should be paid,” she says.
Listen to the full interview on The Conversation Weekly podcast, and subscribe wherever you get your podcasts. You can also read an article Anna Molas wrote about her research, which is part of Women’s Health Matters – a series about the health and wellbeing of women and girls around the world.


U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 



